Telehealth promises to be an affordable alternative for dementia care

Telehealth delivery of dementia care in the home can be as effective as face-to-face home visit services if carers and recipients take advantage of the technologies available, Australian researchers say.

Dementia affects almost 50 million people worldwide, which is predicted to increase to 131.5 million people by 2050. Every three seconds someone in the world develops dementia.

The study of 63 people living with mild to moderate dementia, and their care partners, found that telehealth services using videoconferences can save travel time - particularly in rural and remote areas - and equip families with strategies to promote independence in the person with dementia.

Giving care partners strategies to cope with, and delay, functional decline in people living with dementia is a priority, given that about 70% of people with dementia live in their own home with support from family members and friends for assistance. Giving families evidence-based information and skills can promote independence and improve quality of life and wellbeing for people with dementia."

Kate Laver, ARC Discovery Early Career Research Fellow, Occupational Therapist, Lead Researcher, Flinders University Associate Professor

Telehealth promises to provide a more affordable alternative for older people living at home, including those with chronic health conditions.

Researchers conclude that the use of telehealth technologies to deliver non-pharmacologic interventions for people with dementia and their care partners may reduce the costs of delivering the intervention, increase accessibility, and facilitate research translation.

Source:
Journal reference:

Laver, K., et al. (2020) Does Telehealth Delivery of a Dyadic Dementia Care Program Provide a Noninferior Alternative to Face-To-Face Delivery of the Same Program? A Randomized, Controlled Trial. American Journal of Geriatric Psychiatry. doi.org/10.1016/j.jagp.2020.02.009.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New protein target offers promise for alleviating cognitive decline in Parkinson's disease